Thursday, September 21, 2017 10:15 PM ET
Aldeyra Therapeutics (ALDX) Insider Makes Significant Share purchase Extending the Buying Trend over Last Quarter
One insider — Perceptive Advisors Llc, 10% Owner — today, bought 200,000 shares of Aldeyra Therapeutics having a market value of approximately $1,450,000, as revealed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 296,007 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 496,007 shares and have averaged 248,004 shares per transaction over this time period.
Compared to its peers over the last 90 days, insider buy/sell trading at Aldeyra Therapeutics is greater than the 266-company peer group average. Bio Therapeutic Drugs peer group saw 302 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Aldeyra Therapeutics insiders was also higher. Within the peer group there were 8,385,714 shares purchased and 15,494,310 shares sold with company insiders having sold 23,538 shares on average.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data sourced to compose and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.